CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies have?
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies has 468 citations in the OpenAlex counts ScholarIQ stores.
When was CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies published?
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies has 2017 year in the ScholarIQ index.
What is the open-access status of CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies?
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies has bronze oa status in the ScholarIQ index.
What is the DOI of CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies?
The DOI for CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies is on the source record.
What is the PMID of CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies?
The PMID for CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies is on the source record.
What is the OpenAlex record for CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies?
The OpenAlex for CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies is on the source record.